Occurrence of toxigenic fungi in herbal drugs

Detalhes bibliográficos
Autor(a) principal: Bugno,Adriana
Data de Publicação: 2006
Outros Autores: Almodovar,Adriana Aparecida Buzzo, Pereira,Tatiana Caldas, Pinto,Terezinha de Jesus Andreoli, Sabino,Myrna
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Brazilian Journal of Microbiology
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1517-83822006000100009
Resumo: The increase in the consumption of natural drugs have made their use a Public Health problem due to the possibility of access to products without adequate conditions of use. The concern with the quality of the natural products is due to the potential fungal contamination and the risk of the presence of mycotoxins. Ninety-one samples of medicinal plants were evaluated for the fungal contamination and the mycotoxigenic potential of Aspergillus and Penicillium isolated from the samples. Results indicated that predominant mycoflora was distributed in 10 genera. From these, 89.9% of the isolates corresponded to genera Aspergillus and Penicillium, which are extremely important from the mycotoxicological standpoint. 21.97% of the Aspergillus and Penicillium isolates proved to have the ability for producing aflatoxins (42.9%), ochratoxin A (22.4%) and citrinine (34.7%). The presence of toxigenic moulds represents a potential risk of mycotoxin contamination and considering the worldwide increased use of herbal products as alternative medicines, it is necessary setting standards for toxigenic moulds in crude herbal drugs in order to reduce the risks for consumers' health.
id SBM-1_a2bbd8f73783289ff15fb1bdd2c079ab
oai_identifier_str oai:scielo:S1517-83822006000100009
network_acronym_str SBM-1
network_name_str Brazilian Journal of Microbiology
repository_id_str
spelling Occurrence of toxigenic fungi in herbal drugsherbal drugsmedicinal plantstoxigenic mouldsmycotoxinsThe increase in the consumption of natural drugs have made their use a Public Health problem due to the possibility of access to products without adequate conditions of use. The concern with the quality of the natural products is due to the potential fungal contamination and the risk of the presence of mycotoxins. Ninety-one samples of medicinal plants were evaluated for the fungal contamination and the mycotoxigenic potential of Aspergillus and Penicillium isolated from the samples. Results indicated that predominant mycoflora was distributed in 10 genera. From these, 89.9% of the isolates corresponded to genera Aspergillus and Penicillium, which are extremely important from the mycotoxicological standpoint. 21.97% of the Aspergillus and Penicillium isolates proved to have the ability for producing aflatoxins (42.9%), ochratoxin A (22.4%) and citrinine (34.7%). The presence of toxigenic moulds represents a potential risk of mycotoxin contamination and considering the worldwide increased use of herbal products as alternative medicines, it is necessary setting standards for toxigenic moulds in crude herbal drugs in order to reduce the risks for consumers' health.Sociedade Brasileira de Microbiologia2006-03-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1517-83822006000100009Brazilian Journal of Microbiology v.37 n.1 2006reponame:Brazilian Journal of Microbiologyinstname:Sociedade Brasileira de Microbiologia (SBM)instacron:SBM10.1590/S1517-83822006000100009info:eu-repo/semantics/openAccessBugno,AdrianaAlmodovar,Adriana Aparecida BuzzoPereira,Tatiana CaldasPinto,Terezinha de Jesus AndreoliSabino,Myrnaeng2006-05-19T00:00:00Zoai:scielo:S1517-83822006000100009Revistahttps://www.scielo.br/j/bjm/ONGhttps://old.scielo.br/oai/scielo-oai.phpbjm@sbmicrobiologia.org.br||mbmartin@usp.br1678-44051517-8382opendoar:2006-05-19T00:00Brazilian Journal of Microbiology - Sociedade Brasileira de Microbiologia (SBM)false
dc.title.none.fl_str_mv Occurrence of toxigenic fungi in herbal drugs
title Occurrence of toxigenic fungi in herbal drugs
spellingShingle Occurrence of toxigenic fungi in herbal drugs
Bugno,Adriana
herbal drugs
medicinal plants
toxigenic moulds
mycotoxins
title_short Occurrence of toxigenic fungi in herbal drugs
title_full Occurrence of toxigenic fungi in herbal drugs
title_fullStr Occurrence of toxigenic fungi in herbal drugs
title_full_unstemmed Occurrence of toxigenic fungi in herbal drugs
title_sort Occurrence of toxigenic fungi in herbal drugs
author Bugno,Adriana
author_facet Bugno,Adriana
Almodovar,Adriana Aparecida Buzzo
Pereira,Tatiana Caldas
Pinto,Terezinha de Jesus Andreoli
Sabino,Myrna
author_role author
author2 Almodovar,Adriana Aparecida Buzzo
Pereira,Tatiana Caldas
Pinto,Terezinha de Jesus Andreoli
Sabino,Myrna
author2_role author
author
author
author
dc.contributor.author.fl_str_mv Bugno,Adriana
Almodovar,Adriana Aparecida Buzzo
Pereira,Tatiana Caldas
Pinto,Terezinha de Jesus Andreoli
Sabino,Myrna
dc.subject.por.fl_str_mv herbal drugs
medicinal plants
toxigenic moulds
mycotoxins
topic herbal drugs
medicinal plants
toxigenic moulds
mycotoxins
description The increase in the consumption of natural drugs have made their use a Public Health problem due to the possibility of access to products without adequate conditions of use. The concern with the quality of the natural products is due to the potential fungal contamination and the risk of the presence of mycotoxins. Ninety-one samples of medicinal plants were evaluated for the fungal contamination and the mycotoxigenic potential of Aspergillus and Penicillium isolated from the samples. Results indicated that predominant mycoflora was distributed in 10 genera. From these, 89.9% of the isolates corresponded to genera Aspergillus and Penicillium, which are extremely important from the mycotoxicological standpoint. 21.97% of the Aspergillus and Penicillium isolates proved to have the ability for producing aflatoxins (42.9%), ochratoxin A (22.4%) and citrinine (34.7%). The presence of toxigenic moulds represents a potential risk of mycotoxin contamination and considering the worldwide increased use of herbal products as alternative medicines, it is necessary setting standards for toxigenic moulds in crude herbal drugs in order to reduce the risks for consumers' health.
publishDate 2006
dc.date.none.fl_str_mv 2006-03-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1517-83822006000100009
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1517-83822006000100009
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/S1517-83822006000100009
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Sociedade Brasileira de Microbiologia
publisher.none.fl_str_mv Sociedade Brasileira de Microbiologia
dc.source.none.fl_str_mv Brazilian Journal of Microbiology v.37 n.1 2006
reponame:Brazilian Journal of Microbiology
instname:Sociedade Brasileira de Microbiologia (SBM)
instacron:SBM
instname_str Sociedade Brasileira de Microbiologia (SBM)
instacron_str SBM
institution SBM
reponame_str Brazilian Journal of Microbiology
collection Brazilian Journal of Microbiology
repository.name.fl_str_mv Brazilian Journal of Microbiology - Sociedade Brasileira de Microbiologia (SBM)
repository.mail.fl_str_mv bjm@sbmicrobiologia.org.br||mbmartin@usp.br
_version_ 1752122200541888512